295 related articles for article (PubMed ID: 18260723)
1. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy.
Chittithaworn S; Hanprasertpong J; Tungsinmunkong K; Geater A
Asian Pac J Cancer Prev; 2007; 8(4):530-4. PubMed ID: 18260723
[TBL] [Abstract][Full Text] [Related]
2. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
[TBL] [Abstract][Full Text] [Related]
5. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
6. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
7. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
8. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
9. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
10. Outcome and prognostic factors of laparoscopic radical hysterectomy and pelvic lymphadenectomy in 148 patients with stage IB1 cervical cancer.
Yan X; Li G; Shang H; Lin F; Yang X; Zheng F
Int J Gynecol Cancer; 2012 Feb; 22(2):286-90. PubMed ID: 22146764
[TBL] [Abstract][Full Text] [Related]
11. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ABO blood group in patients with early stage cervical cancer treated with radical hysterectomy with pelvic node dissection.
Hanprasertpong J; Jiamset I; Atjimakul T
Tumour Biol; 2016 Jun; 37(6):7421-30. PubMed ID: 26678885
[TBL] [Abstract][Full Text] [Related]
13. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
Gil-Moreno A; Puig O; Pérez-Benavente MA; Díaz B; Vergés R; De la Torre J; Martínez-Palones JM; Xercavins J
J Minim Invasive Gynecol; 2005; 12(2):113-20. PubMed ID: 15904613
[TBL] [Abstract][Full Text] [Related]
14. Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.
Kasamatsu T; Onda T; Sawada M; Kato T; Ikeda S
Gynecol Oncol; 2009 Jul; 114(1):69-74. PubMed ID: 19398126
[TBL] [Abstract][Full Text] [Related]
15. Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.
Pol FJ; Zusterzeel PL; van Ham MA; Kuijpers DA; Bulten J; Massuger LF
Gynecol Oncol; 2015 Sep; 138(3):579-84. PubMed ID: 26126782
[TBL] [Abstract][Full Text] [Related]
16. Which factors predict parametrial involvement in early stage cervical cancer? A Turkish multicenter study.
Kilic C; Cakir C; Yuksel D; Tokgozoglu N; Comert GK; Karalok A; Ureyen I; Turkmen O; Boyraz G; Tasci T; Tekin OM; Turan T
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():63-66. PubMed ID: 31675631
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
[TBL] [Abstract][Full Text] [Related]
18. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J
J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935
[TBL] [Abstract][Full Text] [Related]
19. [Laparoscopic type C1 hysterectomy based on the anatomic landmark of the uterus deep vein and its branches for cervical cancer].
Liang MR; Han DX; Jiang W; Liu H; Li L; Zhong ML; Luo L; Zeng SY
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):288-294. PubMed ID: 29730917
[No Abstract] [Full Text] [Related]
20. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
